Riskpilot← Back to searchSign inGet full accessGeriEk Ab
OYDissolvedY-tunnus 2993606-4Blomstergatan 9-AOther human health activities n.e.c. · NACE 8699Est. 2019— employees
Revenue 2025
EUR 106K
-43% vs 2024
EBITDA margin
59.7%
-37% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
EUR 64K
-29% vs 2024
| Revenue | EUR 106K | -43% |
| EBITDA | EUR 63K | -37% |
| Net profit | EUR 64K | -29% |
| Total assets | EUR 512K | +3% |
| Equity | EUR 512K | +4% |
| Employees | — | — |
Legal name
GeriEk Ab
Y-tunnus number
2993606-4
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
4. huhtikuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Bolagets verksamhetsområde är produktion av läkartjänster för patienter och produktion av utbildnings-, konsulterings- och föreläsningstjänster. Företaget kan producera tidningsartiklar och sakkunningutlåtanden. Bolaget kan äga, förvalta och hyra ut fastigheter, affärslokaler och bostäder samt bilar. Bolaget kan driva värdepappershandel.
Address
Blomstergatan 9-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 224 | 214 | 225 | 185 | 106 |
| Staff expenses | −48 | −48 | −51 | −52 | −16 |
| EBITDA | 160 | 140 | 156 | 101 | 63 |
| Depreciation & amort. | −4 | −40 | −3 | −2 | −2 |
| EBIT | 156 | 100 | 153 | 99 | 62 |
| Net financials | 6 | 23 | −14 | 12 | 14 |
| Profit before tax | 162 | 123 | 140 | 110 | 76 |
| Tax | 33 | 32 | 31 | 21 | 12 |
| Net profit | 129 | 91 | 109 | 90 | 64 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 302 | 367 | 443 | 496 | 512 |
| Equity | 297 | 364 | 440 | 491 | 512 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 6 | 3 | 3 | 5 | 0 |
| Total debt | 6 | 3 | 3 | 5 | 0 |
EBITDA margin
59.7%
This company
15.8%
Market median
+278% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
12.4%
This company
18.4%
Market median
+33% vs market
20212025
Net profit margin
60.0%
This company
8.1%
Market median
+641% vs market
20212025
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
CM Deputy Member | Deputy Member | 2019 |
MP Chief Executive Officer | Chief Executive Officer | 2019 |
JA | Audit | 2025 |
PR Deputy auditor | Deputy auditor | 2025 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GeriEk Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Marianne Eriksson | Deputy Member | 0 companies |
| Miika Per Anders Ek | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |